These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38941608)

  • 1. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
    Malireddi RKS; Sharma BR; Kanneganti TD
    Annu Rev Immunol; 2024 Jun; 42(1):615-645. PubMed ID: 38941608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
    Bouayad A
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
    Lee S; Channappanavar R; Kanneganti TD
    Trends Immunol; 2020 Dec; 41(12):1083-1099. PubMed ID: 33153908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19.
    Karki R; Kanneganti TD
    J Transl Med; 2022 Nov; 20(1):542. PubMed ID: 36419185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19: Perspectives on Innate Immune Evasion.
    Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
    Front Immunol; 2020; 11():580641. PubMed ID: 33101306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity: the first line of defense against SARS-CoV-2.
    Diamond MS; Kanneganti TD
    Nat Immunol; 2022 Feb; 23(2):165-176. PubMed ID: 35105981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences and similarities between innate immune evasion strategies of human coronaviruses.
    Hoenigsperger H; Sivarajan R; Sparrer KM
    Curr Opin Microbiol; 2024 Jun; 79():102466. PubMed ID: 38555743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis.
    Danladi J; Sabir H
    J Neuroimmunol; 2021 Sep; 358():577632. PubMed ID: 34186336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune sensing of coronavirus and viral evasion strategies.
    Kasuga Y; Zhu B; Jang KJ; Yoo JS
    Exp Mol Med; 2021 May; 53(5):723-736. PubMed ID: 33953325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immune Responses against Coronavirus Infections: Friend or Foe?
    Vafaeinezhad A; Atashzar MR; Baharlou R
    Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasomes and SARS-CoV-2 Infection.
    Kaivola J; Nyman TA; Matikainen S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.
    Keam S; Megawati D; Patel SK; Tiwari R; Dhama K; Harapan H
    Rev Med Virol; 2020 Sep; 30(5):e2123. PubMed ID: 32648313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
    O'Connell P; Aldhamen YA
    Hum Vaccin Immunother; 2020 Dec; 16(12):2980-2991. PubMed ID: 32878546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID 19: a clue from innate immunity.
    Birra D; Benucci M; Landolfi L; Merchionda A; Loi G; Amato P; Licata G; Quartuccio L; Triggiani M; Moscato P
    Immunol Res; 2020 Jun; 68(3):161-168. PubMed ID: 32524333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from dermatology about inflammatory responses in Covid-19.
    Criado PR; Pagliari C; Carneiro FRO; Quaresma JAS
    Rev Med Virol; 2020 Sep; 30(5):e2130. PubMed ID: 32656939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
    Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
    Zheng M; Karki R; Williams EP; Yang D; Fitzpatrick E; Vogel P; Jonsson CB; Kanneganti TD
    Nat Immunol; 2021 Jul; 22(7):829-838. PubMed ID: 33963333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.